Secondary spontaneous pneumothorax in a patient with resistant Mycobacterium abscessus infection and systemic sclerosis-associated interstitial lung disease: A case report

Mycobacterium abscessus subsp. abscessus (MABA) is refractory and sometimes fatal especially in an immunocompromised patient. Also, MABA-associated pneumothorax is an extremely rare complication. We report a case of MABA pulmonary infection complicated pneumothorax treated successfully. A 69-year-ol...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory medicine case reports 2023, Vol.46, p.101941, Article 101941
Main Authors: Nishizawa, Yoko, Katsura, Hideki, Sasaki, Yuka, Kudo, Ryoma, Kizuki, Aki, Horimoto, Ai, Ishikawa, Motonao, Takagi, Kae, Kikuchi, Ken, Sakura, Hiroshi, Nitta, Kosaku, Hoshino, Junichi, Ogawa, Tetsuya
Format: Article
Language:English
Subjects:
Clofazimine
Interstitial lung disease
Mycobacterium abscessus
Pheumothorax
Systemic sclerosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mycobacterium abscessus subsp. abscessus (MABA) is refractory and sometimes fatal especially in an immunocompromised patient. Also, MABA-associated pneumothorax is an extremely rare complication. We report a case of MABA pulmonary infection complicated pneumothorax treated successfully. A 69-year-old Japanese female with immunosuppressed systemic sclerosis-associated interstitial lung disease experienced left-sided secondary spontaneous pneumothorax. MABA was detected in the pleural effusion and blood culture. Microbial sensitivity test showed the MABA was sensitive to only amikacin, sitafloxacin, and clofazimine. Combination therapy with these antibiotics including azithromycin achieved remission within three weeks. In the treatment of MABA infection, compliance with microbial sensitivity test is crucial.
ISSN:2213-0071
2213-0071
DOI:10.1016/j.rmcr.2023.101941